Copyright Reports & Markets. All rights reserved.

Global Biologic Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Biologic Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Biologic Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Biologic Drugs Market Size Growth Rate by Type
    • 1.4.2 Humira
    • 1.4.3 Remicade
    • 1.4.4 Rituxan
    • 1.4.5 Enbrel
    • 1.4.6 Lantus
    • 1.4.7 Avastin
    • 1.4.8 Herceptin
    • 1.4.9 Others
  • 1.5 Market by Application
    • 1.5.1 Global Biologic Drugs Market Size Growth Rate by Application
    • 1.5.2 Diabetes
    • 1.5.3 Inflammation
    • 1.5.4 Auto-Immune Diseases
    • 1.5.5 Blood Diseases
    • 1.5.6 Cardiovascular Diseases
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Biologic Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Biologic Drugs Revenue 2015-2026
    • 2.1.2 Global Biologic Drugs Sales 2015-2026
  • 2.2 Global Biologic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Biologic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Biologic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Biologic Drugs Competitor Landscape by Players

  • 3.1 Biologic Drugs Sales by Manufacturers
    • 3.1.1 Biologic Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Biologic Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Biologic Drugs Revenue by Manufacturers
    • 3.2.1 Biologic Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Biologic Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2019
    • 3.2.5 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Biologic Drugs Price by Manufacturers
  • 3.4 Biologic Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Biologic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Biologic Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Biologic Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Biologic Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Biologic Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Biologic Drugs Revenue by Type (2015-2020)
    • 4.1.3 Biologic Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Biologic Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Biologic Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Biologic Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Biologic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Biologic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Biologic Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Biologic Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Biologic Drugs Revenue by Application (2015-2020)
    • 5.1.3 Biologic Drugs Price by Application (2015-2020)
  • 5.2 Biologic Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Biologic Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Biologic Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Biologic Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Biologic Drugs by Country
    • 6.1.1 North America Biologic Drugs Sales by Country
    • 6.1.2 North America Biologic Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Biologic Drugs Market Facts & Figures by Type
  • 6.3 North America Biologic Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Biologic Drugs by Country
    • 7.1.1 Europe Biologic Drugs Sales by Country
    • 7.1.2 Europe Biologic Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Biologic Drugs Market Facts & Figures by Type
  • 7.3 Europe Biologic Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Biologic Drugs by Region
    • 8.1.1 Asia Pacific Biologic Drugs Sales by Region
    • 8.1.2 Asia Pacific Biologic Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Biologic Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Biologic Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Biologic Drugs by Country
    • 9.1.1 Latin America Biologic Drugs Sales by Country
    • 9.1.2 Latin America Biologic Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Biologic Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Biologic Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Biologic Drugs by Country
    • 10.1.1 Middle East and Africa Biologic Drugs Sales by Country
    • 10.1.2 Middle East and Africa Biologic Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Biologic Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Biologic Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Description and Business Overview
    • 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Roche Biologic Drugs Products Offered
    • 11.1.5 Roche Related Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Corporation Information
    • 11.2.2 Abbott Laboratories Description and Business Overview
    • 11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Abbott Laboratories Biologic Drugs Products Offered
    • 11.2.5 Abbott Laboratories Related Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Description and Business Overview
    • 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Biologic Drugs Products Offered
    • 11.3.5 Johnson & Johnson Related Developments
  • 11.4 Merck & Co.
    • 11.4.1 Merck & Co. Corporation Information
    • 11.4.2 Merck & Co. Description and Business Overview
    • 11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck & Co. Biologic Drugs Products Offered
    • 11.4.5 Merck & Co. Related Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Corporation Information
    • 11.5.2 Pfizer Description and Business Overview
    • 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pfizer Biologic Drugs Products Offered
    • 11.5.5 Pfizer Related Developments
  • 11.6 Amgen
    • 11.6.1 Amgen Corporation Information
    • 11.6.2 Amgen Description and Business Overview
    • 11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Amgen Biologic Drugs Products Offered
    • 11.6.5 Amgen Related Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Corporation Information
    • 11.7.2 Sanofi Description and Business Overview
    • 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sanofi Biologic Drugs Products Offered
    • 11.7.5 Sanofi Related Developments
  • 11.8 Novartis
    • 11.8.1 Novartis Corporation Information
    • 11.8.2 Novartis Description and Business Overview
    • 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Novartis Biologic Drugs Products Offered
    • 11.8.5 Novartis Related Developments
  • 11.9 Eli Lilly
    • 11.9.1 Eli Lilly Corporation Information
    • 11.9.2 Eli Lilly Description and Business Overview
    • 11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Eli Lilly Biologic Drugs Products Offered
    • 11.9.5 Eli Lilly Related Developments
  • 11.10 Amgen
    • 11.10.1 Amgen Corporation Information
    • 11.10.2 Amgen Description and Business Overview
    • 11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Amgen Biologic Drugs Products Offered
    • 11.10.5 Amgen Related Developments
  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Description and Business Overview
    • 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Roche Biologic Drugs Products Offered
    • 11.1.5 Roche Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Biologic Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Biologic Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Biologic Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Biologic Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Biologic Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Biologic Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Biologic Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Biologic Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Biologic Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Biologic Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Biologic Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Biologic Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Biologic Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Biologic Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Biologic Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Biologic Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Biologic Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Biologic Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Biologic Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Biologic Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Biologic Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Biologic Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Biologic Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Biologic Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Biologic Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Biologic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Biologic Drugs market is segmented into
    Humira
    Remicade
    Rituxan
    Enbrel
    Lantus
    Avastin
    Herceptin
    Others

    Segment by Application, the Biologic Drugs market is segmented into
    Diabetes
    Inflammation
    Auto-Immune Diseases
    Blood Diseases
    Cardiovascular Diseases
    Others

    Regional and Country-level Analysis
    The Biologic Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Biologic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Biologic Drugs Market Share Analysis
    Biologic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biologic Drugs business, the date to enter into the Biologic Drugs market, Biologic Drugs product introduction, recent developments, etc.

    The major vendors covered:
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Merck & Co.
    Pfizer
    Amgen
    Sanofi
    Novartis
    Eli Lilly
    Amgen

    Buy now